Addition of mitomycin C to cis-diamminedichloroplatinum(ii)/ hyperthermia/radiation therapy in the FSaIIC fibrosarcoma

References

• Alberts D. S., Peng Y.-M., Chen H.-S. G., Moon T. E., Cetas T. C., Hoeschele J. D. Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model. Journal of the National Cancer Institute 1980; 65: 455–461
   PubMed Web of Science ®Google Scholar
• Baker D., Sager H., Constable W., Goodchild N. Response of previously irradiated skin to combinations of x-radiation, hyperthermia and cis-diamminedichloroplatinum. Cancer Investigations 1984; 2: 15–19
   PubMed Web of Science ®Google Scholar
• Born R., Hug O., Trott K. R. The effect of prolonged hypoxia on growth and viability of Chinese hamster ovary cells. International Journal of Radiation Oncology, Biology and Physics 1976; 1: 687–697
   PubMed Web of Science ®Google Scholar
• Chaplin D. J., Durand R. E., Olive P. L. Cell selection from a murine tumor using the fluorescent probe Hoechst 33342. British Journal of Cancer 1985; 51: 569–573
   PubMedGoogle Scholar
• Dewit L. Combined treatment of radiation and cis-diamminedichloroplatinum(ii): a review of experimental and clinical data. International Journal of Radiation Oncology, Biology and Physics 1987; 13: 403–426
   PubMed Web of Science ®Google Scholar
• Douple E. B. Cis-diamminedichloroplatinum(ii): effects of a representative metal coordination complex on mammalian cells. Pharmacology and Therapeutics 1984; 25: 297–326
   PubMed Web of Science ®Google Scholar
• Fisher G. A., Hahn G. M. Enhancement of cis-diamminedichloroplatinum (cis-DDP) cytotoxicity by hyperthermia. 3rd International Symposium: Cancer Therapy by Hyperthetmia, Drugs and Radiation, Monograph 61, L. A. Dethlefsen, W. C. Dewey. National Cancer Institute, Ft Collins, CO 1982; 255–258
   Google Scholar
• Guillino P. M. In vivo utilization of oxygen and glucose by neoplastic tissue. Advances in Experimental Medicine and Biology 1975; 75: 521–536
   Google Scholar
• Gupta V., Costanzi J. J. Role of hypoxia in anticancer drug-induced cytotoxicity for Ehrlich ascites cells. Cancer Research 1987; 47: 2407–2412
   PubMed Web of Science ®Google Scholar
• Harris J. W., Shrieve D. C. Effects of adriamycin and x-rays on euoxic and hypoxic EMT6 cells in vitro. International Journal of Radiation Oncology, Biology and Physics 1979; 5: 1245–1248
   PubMedGoogle Scholar
• Hasegawa T., Rhee J. G., Levitt S. H., Song C. W. Increase in tumor pO2 by perfluorochemicals and carbogen. International Journal of Radiation Oncology, Biology and Physics 1987; 13: 569–574
   PubMed Web of Science ®Google Scholar
• Herman T. S. Temperature dependence of adriamycin, cis-diamminedichloroplatinum, bleomycin and1, 3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity in vitro. Cancer Research 1983; 43: 517–520
   PubMed Web of Science ®Google Scholar
• Herman T. S., Jochelson M. S., Teicher B. A., Scott P. J., Hansen J., Pfeffer M. R., Clark J. R., Gelwan L. E., Molnar-Griffin B. J., Fraser S. M., Svennson G., Bornstein B. A., Coleman C. N. A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies. International Journal of Radiation Oncology, Biology and Physics 1990b; 17: 1273–1279
   Web of Science ®Google Scholar
• Herman T. S., Teicher B. A. Sequencing of trimodality therapy [cis-diamminedichloroplatinum(ii)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma. Cancer Research 1988; 48: 2693–2697
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A., Chan V., Collins L. S., Kaufmann M. E., Loh C. The effect of hyperthermia on the action of cis-diamminedichloroplatinum(ii), (rhodamine-123)2[tetrachloroplatinum(ii)], rhodamine 123 and potassium tetrachloroplatinate in vitro and in vivo. Cancer Research 1988a; 48: 2335–2343
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A., Collins L. S. Effect of hypoxia and acidosis on the cytotoxicity of four platinum complexes at normal and hyperthermia temperatures. Cancer Research 1988c; 48: 2342–2347
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A., Holden S. A. Trimodality therapy (drug/hyperthermia/radiation) with BCNU or mitomycin C. International Journal of Radiation Oncology. Biology and Physics 1990c; 18: 375–382
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A., Holden S. A., Collins L. S. Interaction of hyperthermia and radiation in murine cells: hypoxia and acidosis in vitro, in tumor subpopulations in vivo. Cancer Research 1989; 49: 3338–3343
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A., Holden S. A., Pfeffer M. R., Jones S. M. Addition of 2-nitroimidazole radiosensitizers to trimodality therapy (cis-diamminedichloroplatinum(ii)/hyperthermia/radiation) in the murine FSaIIC fibrosarcoma. Cancer Research 1990a; 50: 2734–2740
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A., Jochelson M., Clark J., Svensson G., Coleman C. N. Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies. International Journal of Hyperthermia 1988b; 4: 143–158
   PubMed Web of Science ®Google Scholar
• Kennedy D. A., McGurl J. D., Leonardis L., Alabaster O. pH dependence of mitomycin C-induced cross-linking activity in EMT6 tumor cells. Cancer Research 1985a; 45: 3541–3547
   PubMedGoogle Scholar
• Kennedy K. A., Mimnaugh E. G., Trush M. A., Sinha B. K. Effects of glutathione and ethylxanthate on mitomycin C activation by isolated rat hepatic or EMT6 mouse mammary tumor nuclei. Cancer Research 1985b; 45: 4071–4076
   Google Scholar
• Kennedy K. A., Teicher B. A., Rockwell S., Sartorelli A. C. The hypoxic tumor cell: a target for selective cancer chemotherapy. Biochemical Pharmacology 1980; 29: 1–8
   PubMed Web of Science ®Google Scholar
• Kennedy K. A., Teicher B. A., Rockwell S., Sartorelli A. C. Chemotherapeutic approaches to cell populations of tumors. Molecular Targets and Actions for Cancer Chemotherapeutic Agents, A. C. Sartorelli, J. R. Bertino, J. S. Lazo. Academic Press, New York 1981; 85–101
   Google Scholar
• Keyes S. R., Fracasso P. M., Heimbrook D. C., Rockwell S., Sligar S. G., Sartorelli A. C. Role of NADPH: cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C. Cancer Research 1984; 44: 5638–5643
   PubMed Web of Science ®Google Scholar
• Keyes S. R., Heimbrook D. C, Fracasso P. M., Rockwell S., Sligar S. G., Sartorelli A. C. Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin C. Advances in Enzyme Regulation 1985a; 23: 291–307
   PubMedGoogle Scholar
• Keyes S. R., Rockwell S., Sartorelli A. C. Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicumarol in vivo and in vitro. Cancer Research 1985b; 45: 213–216
   Google Scholar
• Koch C. J., Kruuv J., Frey H. E. The effect of hypoxia on the generation time of mammalian cells. Radiation Research 1973; 53: 43–48
   PubMedGoogle Scholar
• Lee I., Levitt S. H., Kim T. H., Song C. W. Improvement of radiation therapy by Fluosol-DA 20% and carbogen. 36th Annual Radiation Research Society Meeting. 1988; 112, Abst. Dq-6
   Google Scholar
• Marshall R. S., Rauth A. M. Modification of the cytotoxic activity of mitomycin C by oxygen and ascorbic acid in Chinese hamster ovary cells and a repair-deficient mutant. Cancer Research 1986; 46: 2709–2713
   PubMed Web of Science ®Google Scholar
• Mella O., Dahl O. Timing of combined hyperthermia and1, 3-bis(2-chloroethyl)-1-nitrosourea or cis-diamminedichloroplatinum in BD IX rats with BT4A tumors. Anticancer Research 1985; 5: 259–264
   PubMed Web of Science ®Google Scholar
• Mella O., Eriksen R., Dahl O., Laerum O. D. Acute systemic toxicity of combined cis-diamminedichloroplatinum and hyperthermia in the rat. European Journal of Cancer and Clinical Oncology 1987; 23: 365–373
   PubMedGoogle Scholar
• Momparler R. L. In vitro systems for evaluation of combination chemotherapy. Pharmacology and Therapeutics. Part A: Chemotherapy, Toxicology, and Metabolic Inhibitors 1980; 8: 21–35
   Google Scholar
• Murthy M. S., Rao L. N., Khandekar J. D., Scanlon E. F. Enhanced therapeutic efficacy of cisplatin by combination with diethyldithio-carbamate and hyperthermia in a mouse model. Cancer Research 1987; 47: 774–779
   PubMed Web of Science ®Google Scholar
• Nias A. H. W. Radiation and platinum drug interaction. International Journal of Radiation Biology 1985; 48: 297–314
   Web of Science ®Google Scholar
• Olive P. J., Chaplin D. J., Durand R. E. Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumors. British Journal of Cancer 1985; 52: 739–746
   PubMedGoogle Scholar
• Rauth A. M., Mohindra J. K., Tannock I. F. Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo. Cancer Research 1983; 43: 4154–4158
   PubMed Web of Science ®Google Scholar
• Rice L., Urando M., Suit H. D. The radiosensitivity of a murine fibrosarcoma as measured by three cell survival assays. British Journal of Cancer 1980; 41: 240–245
   Web of Science ®Google Scholar
• Sartorelli A. C. The role of mitomycin antibiotics in the chemotherapy of solid tumors. Biochemical Pharmacology 1986; 35: 67–69
   PubMedGoogle Scholar
• Sartorelli A. C. Therapeutic attack of hypoxic cells of solid tumors: Presidential address. Cancer Research 1988; 48: 775–778
   PubMedGoogle Scholar
• Siemann D. W., Keng P. C. Characterization of radiation resistant hypoxic cell subpopulations in KHT sarcomas. (ii). Cell Sorting. British Journal of Cancer 1988; 58: 296–300
   PubMedGoogle Scholar
• Song C. W., Lee I., Hasegawa T., Rhee J. G., Levitt S. H. Increase in pO2 and sensitivity of tumors of Fluosol-DA (20%) and carbogen. Cancer Research 1987; 47: 442–446
   PubMed Web of Science ®Google Scholar
• Stephens T. C., Adams K., Peacock J. H., Steel G. G. Temporal interactions in the Lewis lung tumor between cytotoxic drugs and acute or fractionated radiotherapy. Radiotherapy and Oncology 1986; 5: 137–146
   PubMedGoogle Scholar
• Teicher B. A., Rose C. M. Perfluorochemical emulsion can increase tumor radiosensitivity. Science 1984; 223: 934–936
   PubMed Web of Science ®Google Scholar
• Teicher B. A., Sartorelli A. C. Selective attachment of hypoxic tumor cells. Design of Models for Screening of Therapeutic Agents for Cancer, I. J. Fidler, R. J. White. Van Nostrand Reinhold, New York 1981; 19–37
   Google Scholar
• Teicher B. A., Herman T. S., Holden S. A. Combined modality therapy with bleomycin/hyperthermia/radiation. Cancer Research 1988; 48: 6291–6297
   PubMed Web of Science ®Google Scholar
• Teicher B. A., Kowal C. D., Kennedy K. A., Sartorelli A. C. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cacer Research 1981a; 41: 1096–1099
   PubMed Web of Science ®Google Scholar
• Teicher B. A., Lazo J. S., Sartorelli A. C. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Research 1981b; 41: 73–81
   PubMed Web of Science ®Google Scholar
• Vaupel P., Frinak S., Bicher H. I. Heterogenous oxygen partial pressure and pH distribution in C3H mouse mammary adenocarcinoma. Cancer Research 1981; 41: 2008–2013
   PubMed Web of Science ®Google Scholar
• Vaupel P., Fortmeyer H. P., Runkel S., Kallinowski F. Blood flow, oxygen consumption and tissue oxygenation of human breast cancer xenografts in nude rats. Cancer Research 1987; 47: 3496–3503
   PubMed Web of Science ®Google Scholar
• Von der Maase H. Experimental studies on the interaction of radiation and cancer chemotherapeutic drugs in normal tissues and a solid tumor. Radiotherapy and Oncology 1986; 7: 47–68
   PubMed Web of Science ®Google Scholar
• Wallner K. E., Banda M., Li G. C. Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cells. Cancer Research 1987; 47: 1308–1312
   PubMed Web of Science ®Google Scholar
• Wallner K. E., Li G. C. Effect of drug exposure duration and sequencing on hyperthermic potentiation of mitomycin C and cisplatin. Cancer Research 1987; 47: 493–495
   PubMed Web of Science ®Google Scholar
• Weissberg J. B., Son Y. H., Papac R. J., Sasaki C., Fischer D. B., Lawrence R., Rockwell S., Sartorelli A. C., Fischer J. J. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. International Journal of Radiation Oncology, Biology and Physics 1989; 17: 3–9
   PubMed Web of Science ®Google Scholar
• Zar J. H. Bio statistical Analysis. Prentice Hall, Englewood Cliffs, NJ 1984; 199–202
   Google Scholar